Main > DERMATOLOGY > Psoriasis>Plaque Psoriasis (**) > Treatment > Co: USA. A. AdalimuMAb BioSimilar *
Co: USA. A. AdalimuMAb BioSimilar *'s subsections
(*) EU Approval Date: 2017. 03.23
(*) USA Approval Date: 2016. 09.23
Company
TradeMark
TradeMark Web-Site
Co: USA. A. AdalimuMAb BioSimilar *'s products
This section has no products